EUVIMEDEUVIMED entdecken
Open Access

To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis

Jing Li, Binghai Huang, Qifang Lao, Longtao Zou, Kaiqing Xie iD

Therapeutic Apheresis and Dialysis · 2026

DOI: 10.1111/1744-9987.14240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2026. Verfasst von Jing Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Wuzhou Red Cross Hospital, Wuzhou, China. Hauptthemen laut MEDLINE: Plasma Exchange, Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To investigate the clinical efficacy and safety of plasma exchange (PE) in the treatment of glucocorticoid‐insensitive patients with serum anti‐ N ‐methyl‐ d ‐aspartate (anti‐NMDA) receptor antibody‐negative and serum anti‐NMDA receptor antibody‐positive encephalitis.

Methods

The clinical data of 20 patients with anti‐NMDA receptor antibody encephalitis treated between January 2015 and December 2022 were collected. The general information, clinical symptoms, auxiliary examination, treatment (hormone, PE, etc.), adverse reactions, clinical efficacy, and other related data were retrospectively compared and analyzed.

Results

A total of 8 cases had adverse reactions (9.76%, 8/82), including 4 cases (4.88%, 4/82) of allergy and 2 cases (2.44%,2/82) of thrombocytopenia. In patients with anti‐NMDA receptor antibody encephalitis who were not sensitive to glucocorticoids, the effective rate of PE was 80.0% ( p = 0.0005).

Conclusion

PE combined with glucocorticoid is more effective than glucocorticoid alone in the treatment of anti‐NMDA receptor antibody encephalitis patients with positive or negative anti‐NMDA receptor antibodies. Most adverse reactions were mild and easy to manage. It does not cause obvious blood cell loss. PE is a safe and acceptable treatment. However, our study has limitations, and due to the small number of people and the fact that plasmapheresis was performed after glucocorticoid therapy, further prospective clinical studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma ExchangeAnti-N-Methyl-D-Aspartate Receptor EncephalitisHumansFemaleMaleRetrospective StudiesTreatment OutcomeGlucocorticoidsAdultMiddle AgedReceptors, N-Methyl-D-AspartateAutoantibodiesAgedAdolescentYoung Adult

Stichwörter der Autor:innen

anti‐NMDA receptorefficacyencephalitisplasma exchangesafety

Substanzen

GlucocorticoidsReceptors, N-Methyl-D-AspartateAutoantibodies

Autor:innen und Institutionen

  • Department of Nephrology, Wuzhou Red Cross Hospital, Wuzhou, China.
  • General Internal Medicine, Guangxi Medical University Cancer Hospital, Nanning, China.
  • Department of Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Department of Nephrology, Yulin First People's Hospital, Nanning, China.
  • Department of Intensive Care Medicine, Guangxi Medical University Cancer Hospital, Nanning, China.

ORCID-Profile: Kaiqing Xie

Zitieren

APA

Li, J., Huang, B., Lao, Q., Zou, L., & Xie, K. (2026). To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14240

Vancouver

Li J, Huang B, Lao Q, Zou L, Xie K. To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis. Therapeutic Apheresis and Dialysis. 2026. doi:10.1111/1744-9987.14240

BibTeX
@article{Li2026,
  author = {Li, Jing and Huang, Binghai and Lao, Qifang and Zou, Longtao and Xie, Kaiqing},
  title = {To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  doi = {10.1111/1744-9987.14240}
}
Kostenlos starten →